Cargando…
Oncolytic reovirus preferentially induces apoptosis in KRAS mutant colorectal cancer cells, and synergizes with irinotecan
Reovirus is a double stranded RNA virus, with an intrinsic preference for replication in KRAS mutant cells. As 45% of human colorectal cancers (CRC) harbor KRAS mutations, we sought to investigate its efficacy in KRAS mutant CRC cells, and examine its impact in combination with the topoisimerase-1 i...
Autores principales: | Maitra, Radhashree, Seetharam, Raviraja, Tesfa, Lydia, Augustine, Titto A., Klampfer, Lidija, Coffey, Matthew C., Mariadason, John M., Goel, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058046/ https://www.ncbi.nlm.nih.gov/pubmed/24798549 |
Ejemplares similares
-
Immune characterization of metastatic colorectal cancer patients post reovirus administration
por: Parakrama, Ruwan, et al.
Publicado: (2020) -
Toll-like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancer
por: Maitra, Radhashree, et al.
Publicado: (2017) -
Noncoding RNA Profile in Reovirus Treated KRAS-Mutated Colorectal Cancer Patients
por: Saperstein, Rafael, et al.
Publicado: (2023) -
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer
por: Augustine, Titto, et al.
Publicado: (2022) -
Transcriptome Signature of Immune Cells Post Reovirus Treatment in KRAS Mutated Colorectal Cancer
por: Fogel, Elisha J, et al.
Publicado: (2021)